Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Medidata Solutions

Biotech & Life Sciences · New York City, United States · Founded 1999 · IPO 2009 Unicorn

Saas-based clinical development solutions addressing the functioning of customers' clinical trials

Valuation
$5.80B
Market cap · 2026
Revenue
$636M
Latest reported FY
EBITDA
$215M
Latest reported FY

Investors

3 investors on Medidata Solutions's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Medidata Solutions
Silicon Alley Venture Partners
Series B+ 1 investor entered at this stage

Global footprint

Where Medidata Solutions has talent and traffic

AI talent share
2.3% of workforce is AI talent
(65 of 2,798 staff)
Core AI130.46%
Other AI521.86%
Non-AI workforce2,73397.68%
Workforce by country
27 countries with
team presence
🇺🇸 United States75.4%
🇬🇧 United Kingdom12.7%
🇨🇳 China3.2%
🇯🇵 Japan2.8%
🇰🇷 South Korea1.5%
Top 5 of 27 shown
Web traffic by country
130K monthly visits
across markets
🇺🇸 United States44.2%
🇮🇳 India9.5%
🇨🇦 Canada5.1%
🇨🇭 Switzerland4.5%
🇬🇧 United Kingdom4.1%
Top 5 markets shown

Patent intelligence

$70M patent portfolio · 90 active families

Estimated portfolio value
$70M
1.2% of market cap · smaller than top peer Verily ($283M)
90 active patent families
Where Medidata Solutions innovates Electronic equipmentData scienceUser roleMedical careMobile analytics

Where Medidata Solutions concentrates vs peers

Each axis is a top-10 topic across Medidata Solutions and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Medidata Solutions's 9 investments and acquisitions.

Every disclosed deal where Medidata Solutions appeared as a backer or acquirer, 2002–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

9 deals across Medidata Solutions's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Medidata Solutions deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Medidata Solutions's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        9 of 9 deals

        Market sentiment

        What the market is saying about Medidata Solutions

        An AI-synthesized read of the highest-engagement posts about Medidata Solutions on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Medidata Solutions on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.